TECH - Company ID 0000842023
BIO-TECHNE Corp trades as TECH and has a market capitalization of $11.14 B, making it the #891 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.22B, up 5.2% from the prior year and net income of $73.40M. This page tracks BIO-TECHNE Corp through 1,229 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years BIO-TECHNE Corp's revenue grew from $499.02M to $1.22B, a compound annual growth rate of 10.4%. Net profit margin compressed from 20.9% to 6.0% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-12 |
| Insider sale notice | 144 | 2026-05-08 |
| Insider trade | 4 | 2026-05-07 |
| Insider trade | 4 | 2026-05-07 |
| Insider trade | 4 | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-06 |
| SCHEDULE 13G | - | 2026-05-06 |
Bio-Techne Declares Dividend :: Bio-Techne Corporation (TECH)
Bio-Techne Releases Third Quarter Fiscal 2026 Results :: Bio-Techne Corporation (TECH)
Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference :: Bio-Techne Corporation (TECH)
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity :: Bio-Techne Corporation (TECH)
Access to the discussion may be obtained as follows:
The largest companies sharing BIO-TECHNE Corp's SEC industry classification (biological products, (no diagnostic substances)).
BIO-TECHNE Corp (TECH) has a market capitalization of $11.14 B as of 2026-07-09, ranking #891 among US-listed companies.
BIO-TECHNE Corp reported revenue of $1.22B for fiscal year 2025, an increase of 5.2% year over year.
Yes. BIO-TECHNE Corp reported net income of $73.40M in its latest fiscal year.